Publisher Correction: A pan-serotype dengue virus inhibitor targeting the NS3-NS4B interaction

Suzanne J F Kaptein¹, Olivia Goethals², Dominik Kiemel³, Arnaud Marchand⁴, Bart Kesteleyn⁵, Jean-François Bonfanti^{6

7}, Dorothée Bardiot⁴, Bart Stoops⁵, Tim H M Jonckers⁵, Kai Dallmeier¹, Peggy Geluykens^{5

8}, Kim Thys⁵, Marjolein Crabbe⁵, Laurent Chatel-Chaix^{3

9}, Max Münster³, Gilles Querat¹⁰, Franck Touret¹⁰, Xavier de Lamballerie¹⁰, Pierre Raboisson^{5

11}, Kenny Simmen⁵, Patrick Chaltin^{4

12}, Ralf Bartenschlager^{3

13}, Marnix Van Loock¹⁴, Johan Neyts^{15

16}

Affiliations

¹ Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
² Janssen Global Public Health, Janssen Pharmaceutica, Beerse, Belgium.
³ Department of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany.
⁴ Cistim Leuven, Leuven, Belgium.
⁵ Janssen Research & Development, Janssen Pharmaceutica, Beerse, Belgium.
⁶ Janssen Infectious Diseases Discovery, Janssen-Cilag, Val de Reuil, France.
⁷ Galapagos, Romainville, France.
⁸ Charles River Beerse, Discovery, Beerse, Belgium.
⁹ Institut National de la Recherche Scientifique, Centre Armand-Frappier Santé Biotechnologie, Quebec, Quebec, Canada.
¹⁰ Unité des Virus Émergents (UVE), Aix-Marseille Univ, IRD 190 Inserm 1207, IHU Méditerranée Infection, Marseille, France.
¹¹ Aligos, Leuven, Belgium.
¹² Centre for Drug Design and Discovery (CD3), KU Leuven, Leuven, Belgium.
¹³ German Center for Infection Research, Heidelberg Partner Site, Heidelberg, Germany.
¹⁴ Janssen Global Public Health, Janssen Pharmaceutica, Beerse, Belgium. mvloock@its.jnj.com.
¹⁵ Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium. johan.neyts@kuleuven.be.
¹⁶ Global Virus Network (GVN), Baltimore, MD, USA. johan.neyts@kuleuven.be.

Published Erratum

Suzanne J F Kaptein et al. Nature. 2021 Nov.

. 2021 Nov;599(7883):E2.

doi: 10.1038/s41586-021-04123-9.

¹ Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
² Janssen Global Public Health, Janssen Pharmaceutica, Beerse, Belgium.
³ Department of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany.
⁴ Cistim Leuven, Leuven, Belgium.
⁵ Janssen Research & Development, Janssen Pharmaceutica, Beerse, Belgium.
⁶ Janssen Infectious Diseases Discovery, Janssen-Cilag, Val de Reuil, France.
⁷ Galapagos, Romainville, France.
⁸ Charles River Beerse, Discovery, Beerse, Belgium.
⁹ Institut National de la Recherche Scientifique, Centre Armand-Frappier Santé Biotechnologie, Quebec, Quebec, Canada.
¹⁰ Unité des Virus Émergents (UVE), Aix-Marseille Univ, IRD 190 Inserm 1207, IHU Méditerranée Infection, Marseille, France.
¹¹ Aligos, Leuven, Belgium.
¹² Centre for Drug Design and Discovery (CD3), KU Leuven, Leuven, Belgium.
¹³ German Center for Infection Research, Heidelberg Partner Site, Heidelberg, Germany.
¹⁴ Janssen Global Public Health, Janssen Pharmaceutica, Beerse, Belgium. mvloock@its.jnj.com.
¹⁵ Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium. johan.neyts@kuleuven.be.
¹⁶ Global Virus Network (GVN), Baltimore, MD, USA. johan.neyts@kuleuven.be.

No abstract available

Erratum for

A pan-serotype dengue virus inhibitor targeting the NS3-NS4B interaction.
Kaptein SJF, Goethals O, Kiemel D, Marchand A, Kesteleyn B, Bonfanti JF, Bardiot D, Stoops B, Jonckers THM, Dallmeier K, Geluykens P, Thys K, Crabbe M, Chatel-Chaix L, Münster M, Querat G, Touret F, de Lamballerie X, Raboisson P, Simmen K, Chaltin P, Bartenschlager R, Van Loock M, Neyts J. Kaptein SJF, et al. Nature. 2021 Oct;598(7881):504-509. doi: 10.1038/s41586-021-03990-6. Epub 2021 Oct 6. Nature. 2021. PMID: 34616043

1. Low, J. G., Ooi, E. E. & Vasudevan, S. G. Current status of dengue therapeutic research and development. J. Infect. Dis. 215, S96–S102 (2017).
1. Unlocking the Potential of Preventive Therapies for Malaria. World Health Organization, https://www.who.int/malaria/media/preventive-therapies/en/ (7 April 2017).